About Emulate, Inc.

Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing.

Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection and have also been awarded Product Design of the Year 2015 by London’s Design Museum.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
The Innovation & Design Building, Drydock Avenue, Boston, MA 02210, US
description icon
Founded
2014
description icon
Keywords
Precision Medicine, Personalized Health, Emulating Human Biology, Understanding Disease

Emulate, Inc. Alternatives

Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about Emulate, Inc.

Who is the CEO of Emulate, Inc.?

Megan Mclachlan Connolly is the CEO of Emulate, Inc.. To contact Megan Mclachlan Connolly email at [email protected] or [email protected].

Who are the decision makers in Emulate, Inc.?

The decision makers in Emulate, Inc. are Christine M, Jim Corbett, Kirsty Zhe Lyu, etc. Click to Find Emulate, Inc. decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more